Discovery and development of the BHAP nonnucleoside reverse transcriptase inhibitor delavirdine mesylate.
Discovery Chemistry, Pharmacia & Upjohn, Inc., Kalamazoo, Michigan 49001-0199, USA.
W J
WJ
Adams
P A
PA
Aristoff
R K
RK
Jensen
W
W
Morozowich
D L
DL
Romero
W C
WC
Schinzer
W G
WG
Tarpley
R C
RC
Thomas
D000818:Animals; D019380:Anti-HIV Agents / Q000138:chemical synthesis* / Q000378:metabolism; D020008:Delavirdine / Q000138:chemical synthesis* / Q000378:metabolism / Q000627:therapeutic use; D015195:Drug Design; D006801:Humans; D018894:Reverse Transcriptase Inhibitors / Q000138:chemical synthesis* / Q000378:metabolism
D019380:Anti-HIV Agents; D018894:Reverse Transcriptase Inhibitors; D020008:Delavirdine